Hilary Kramer
Keep Your Eye on The Fed (And Baby FANG) As Trade Clouds Recede
Wall Street is finally starting to remember that it loves roller coasters more than it dreads uncertainty. After all, doubt always will be with us, but thrills are what make life in the market both fun and lucrative. And thrills are a product of stocks climbing big walls of worry, picking up power day after […]
Bigger Isn’t Better
Big Cannabis took a critical turn this week, with the major cultivators I track rebounding 13 percent. They still have a long way to go before reversing all the summer’s losses, but this is a step in the right direction. The catalyst, ironically, was industry giant Aurora Cannabis Inc. (NYSE:ACB) deciding to exit its 10 […]
How Rich Are These Stocks?
I often hear two complaints about investing in Big Cannabis stocks. First, all these companies look alike. Second, they’re all wildly overpriced. The truth is a little more complicated. Aurora Cannabis Inc. (NYSE:ACB), Tilray Inc. (NASDAQ:TLRY), Cronos Group Inc. (NASDAQ:CRON) and Canopy Growth Corp. (NYSE:CGC) all compete for cannabis sales contracts, so they are all […]
Back to School: How To Survive Wall Street’s Coming Doldrums
Hilary Kramer discusses and explains how investors can profit by buying and selling stocks during Wall Street’s coming doldrums.
These Dogs of The Dow Won’t Hunt
It has been a pretty good year so far on Wall Street, but I can’t help but notice how much the Dow Jones Industrial Average is lagging in both the broad market and the technology-rich Nasdaq. Too many blue-chip behemoths look vulnerable right now. Ordinarily, investors would see this as an opportunity to deploy a […]
Cannabis Corner: Too Small to Trade?
Anyone who has been in the market for any length of time knows that while start-up companies have more room to grow, achieving their ultimate potential is a precarious and often lengthy process. That’s why a conventional short-term investment outlook doesn’t really work on this end of Wall Street. You need to think like a […]